LifeTech Scientific Corporation (HKG:1302)

Market Cap	8.15B
Revenue (ttm)	1.45B
Net Income (ttm)	78.79M
Shares Out	4.63B
EPS (ttm)	0.02
PE Ratio	96.97
Forward PE	17.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,440,000
Average Volume	29,450,900
Open	1.800
Previous Close	1.800
Day's Range	1.750 - 1.800
52-Week Range	1.240 - 2.330
Beta	1.20
RSI	35.47
Earnings Date	Nov 14, 2025

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,395
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2024, LifeTech Scientific's revenue was 1.30 billion, an increase of 2.88% compared to the previous year's 1.27 billion. Earnings were 222.39 million, a decrease of -15.52%.

Financial numbers in CNY